A concise overview of ground breaking novel incretin-based therapies, including GLP-1 receptor agonists and DPP-4 inhibitors Ideal for busy clinicians who encounter patients with type 2 diabetes on a daily basis and are interested in a clinically-applicable introduction to incretin-based therapies Includes the most up-to-date clinical guidelines, recent clinical trials and expert discussions of established and emerging therapies for patients with type 2 diabetes Includes supplementary material: sn.pub/extras
Stephen Gough
Diabetes Type 2 diabetes DPP-4 inhibitor GLP-1 analogue Incretin Dipeptidyl peptidase-4 inhibitor Gliptins Glucagon-like peptide-1 agonist Incretin mimetics Oral hypoglycemics Oral antidiabetics Sitagliptin Saxagliptin Vildagliptin Alogliptin
()
()